查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1887034

安全採血針市場規模、佔有率、成長及全球產業分析：依類型、應用和地區劃分的洞察，以及2024-2032年預測

Safety Lancets Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 200 Pages | 商品交期: 請詢問到貨日

價格

安全採血針市場成長推動因素

隨著醫療保健系統優先考慮更安全的採血和糖尿病管理解決方案，全球安全採血針市場持續快速成長。根據最新的產業評估，2024年安全採血針市場規模達10.9億美元。預計到2025年，該市場將進一步成長至12.1億美元，到2032年將成長近一倍，達到26億美元，預測期內複合年增長率高達11.5%。這一持續增長的推動因素包括糖尿病盛行率的上升、家庭醫療保健的擴展以及監管機構對臨床和非臨床環境中安全針頭操作的日益重視。

北美將在2024年佔最大的市場佔有率，達到37.61%，反映出該地區疾病負擔沉重、健保報銷力度大，以及先進安全採血針產品普及率高。美國市場受益於聯邦醫療保險（Medicare）的覆蓋範圍，該保險為參加聯邦醫療保險B部分（Medicare Part B）的胰島素依賴型糖尿病患者每三個月報銷高達300支採血針，從而維持了穩定的需求。

慢性病負擔加重推動市場擴張

全球糖尿病盛行率的不斷上升仍然是安全採血針普及的主要推動因素。根據健康指標與評估研究所（IHME，2023）的數據，全球有超過5億人患有糖尿病。這種快速增長增加了對準確、頻繁血糖監測的需求，顯著提高了毛細血管採血安全採血針的使用量。這些設備具有防針刺傷功能，確保操作更安全，並降低病患和醫護人員的感染風險。

市場也受惠於血糖自我監測 (SMBG) 的日益普及，患者越來越傾向於使用安全易用的採血針進行居家檢測。例如，2023 年發表在 "印度醫學專科雜誌" 上的一項研究發現，印度有 35% 的患者在家中監測血糖，凸顯了醫療保健分散化的趨勢。

低收入市場的成本障礙限制了其普及化

儘管安全採血針具有臨床優勢，但在對成本敏感的地區，它們面臨挑戰。安全採血針比傳統採血針貴，構成了一大障礙。在英國，2020 年 NHS 的數據顯示，安全採血針每 100 支的價格在 4.87 美元到 5.06 美元之間，而標準採血針每 100 支的價格在 2.37 美元到 4.22 美元之間。在發展中市場，有限的醫療保健支出和醫療器材報銷額度較低阻礙了醫療器材的廣泛應用和市場滲透。

家庭醫療保健需求的成長創造了巨大的機會

家庭診斷的興起正在開闢新的成長管道。家庭用戶需要便利、無痛且安全的採血工具，因此安全採血針成為理想之選。許多政府正在推廣家庭慢性病管理，以減輕醫院的負擔，這進一步推動了需求。需要使用採血針的家用糖化血紅蛋白 (HbA1c) 檢測試劑盒和膽固醇檢測設備的日益普及也促進了市場擴張。

細分市場概覽

依類型

  • 由於其易用性和較高的臨床應用率，依鈕式安全採血針將在 2024 年引領市場。
  • 壓力/觸摸式採血針的特點是穿刺深度一致且意外暴露風險較低，其市場正在迅速擴張。

依切口類型

  • 針式採血針因其疼痛感低、安全性高且適用於頻繁檢測，在2024年成為主流。
  • 刀片式採血針因其採集血量較多，在新生兒篩檢和乾血斑 (DBS) 檢測中越來越受到關注。

依年齡組

  • 由於糖化血紅蛋白 (HbA1c)、膽固醇和血糖檢測頻率高，成人族群將在2024年佔最大佔有率。
  • 由於第1型糖尿病需要常規檢測，兒科族群是成長最快的族群。

依應用

  • 受全球糖尿病負擔日益加重的影響，血糖監測在2024年仍將是最大的應用領域。
  • 血紅素檢測、膽固醇分析和乾血斑檢測也顯著促進了需求成長。

區域展望

北美（2024 年 4.1 億美元）

糖尿病高發生率、聯邦醫療保險覆蓋範圍廣以及實力雄厚的製造商的存在是北美市場的主要推動因素。

歐洲

在先進的醫療保健體系的支持下，該地區的普及率很高。 2020年，英格蘭和威爾斯的國民醫療服務體系（NHS）在安全採血針上的支出為1,342萬美元。

亞太地區

中國和印度是成長最快的地區，這主要得益於兩國龐大的糖尿病人口和不斷擴大的國內製造業。

拉丁美洲

糖尿病患者數量的增加和家庭監測的日益普及推動了該地區的成長。

中東和非洲

政府對非傳染性疾病的關注推動了該地區的逐步擴張。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場推動因素
  • 市場阻礙因素
  • 市場機遇
  • 市場趨勢

第四章：主要發現

  • 主要國家/地區主要疾病盛行率（2024 年）
  • 主要國家/地區 SMBG 使用者數量（2024 年）
  • 安全採血針的進展
  • 概述：報銷情況
  • 主要產業趨勢（併購、合作、等等）

第五章：全球安全採血針市場分析、洞察與預測（2019-2032）

  • 市場分析、洞察與預測 - 依類型劃分
    • 依鈕式
    • 壓力/觸摸式
  • 市場分析、洞察與預測 - 依切口類型劃分
    • 針頭式
    • 刀片式
  • 市場分析、洞察與預測 - 依年齡組別劃分
    • 成人
    • 兒童
  • 市場分析、洞察與預測 - 依應用劃分
    • 血糖監測
    • 血紅素檢測
    • 膽固醇檢測
    • 其他
  • 市場分析、洞察與預測 - 依最終用途劃分用戶
    • 醫院和診所
    • 家庭醫療保健
    • 其他
  • 市場分析、洞察與預測 - 依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章：北美安全採血針市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 美國
    • 加拿大

第七章：歐洲安全採血針市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 德國
    • 美國王國
    • 法國
    • 義大利
    • 西班牙
    • 斯堪的納維亞
    • 歐洲其他地區

第八章 亞太地區安全採血針市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第九章 拉丁美洲安全採血針市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

章節10：中東和非洲安全採血針市場分析、洞察與預測（2019-2032 年）

  • 依國家劃分
    • 海灣合作委員會 (GCC)
    • 南非
    • 中東和非洲其他地區

第 11 章 競爭分析

  • 全球市佔率分析（2024 年）
  • 公司簡介
    • BD
    • SARSTEDT AG & Co. KG
    • Greiner Bio-One International GmbH
    • HTL-STREFA (MTD Medical Technology and Devices)
    • Terumo Medical Corporation
    • B. Braun SE
    • Abbott
    • Cardinal Health
    • YPSOMED
    • Biosense Technologies Private Limited
Product Code: FBI113261

Growth Factors of safety lancets Market

The global safety lancets market continues to expand rapidly as healthcare systems emphasize safer blood sampling and diabetes management solutions. According to the latest industry assessment, the safety lancets market size reached USD 1.09 billion in 2024. The market is projected to grow further to USD 1.21 billion in 2025 and nearly double to USD 2.60 billion by 2032, exhibiting a strong CAGR of 11.5% during the forecast period. This sustained growth stems from rising diabetes prevalence, expansion in home healthcare, and increasing regulatory focus on safe needle practices across clinical and non-clinical settings.

North America held the largest regional share of 37.61% in 2024, reflecting high disease burden, strong reimbursement support, and strong penetration of advanced safety lancet products. The U.S. market benefits significantly from Medicare coverage, which reimburses up to 300 lancets every 3 months for insulin-dependent diabetic patients under Medicare Part B, driving consistent demand.

Growing Chronic Disease Burden Driving Market Expansion

The global rise in diabetes remains the primary driver for the adoption of safety lancets. According to the Institute for Health Metrics and Evaluation (2023), over 500 million individuals worldwide live with diabetes. This surge has elevated the need for accurate and frequent blood glucose monitoring, significantly boosting the usage of safety lancets for capillary blood collection. These devices provide needle-stick protection, ensure safer handling, and reduce infection risks for both patients and healthcare providers.

The trend toward self-monitoring of blood glucose (SMBG) also supports the market, with patients increasingly preferring safe, easy-to-use lancets for home testing. In India, for example, a 2023 study published in the Indian Journal of Medical Specialties found that 35% of patients performed home glucose monitoring, highlighting the transition toward decentralized care.

Cost Barriers Limit Adoption in Low-Income Markets

Despite their clinical advantages, safety lancets face adoption challenges in cost-sensitive regions. Safety-engineered lancets are priced higher than traditional lancets, and the difference remains a barrier. In the U.K., NHS data from 2020 shows safety lancets can cost USD 4.87-5.06 per 100 units, whereas standard lancets cost USD 2.37-4.22 per 100 units. In developing markets, limited healthcare spending and low device reimbursement restrict widespread use, slowing market penetration.

Rising Home Healthcare Demand Creates Significant Opportunities

The shift toward home-based diagnostics is unlocking new growth avenues. Home-users require simple, painless, and safe blood sampling tools, making safety lancets a preferred choice. Many governments are pushing for at-home chronic disease management to reduce hospital burden, further elevating demand. Growing availability of home HbA1c kits and cholesterol testing devices, all requiring lancets, also supports market expansion.

Segmentation Overview

By Type

  • Button-activated safety lancets led the market in 2024, driven by ease of use and strong adoption in clinical settings.
  • Pressure/contact-activated lancets are expanding rapidly, offering consistent puncture depth and lower risk of accidental exposure.

By Incision Type

  • Needle lancets dominated in 2024, preferred for lower pain, enhanced safety, and suitability for frequent testing.
  • Blade lancets are gaining traction for neonatal screening and dried blood spot (DBS) tests due to their higher blood yield.

By Age Group

  • Adults accounted for the largest share in 2024, attributed to high testing volumes for HbA1c, cholesterol, and blood glucose.
  • Pediatrics is the fastest-growing segment due to daily testing needs in Type 1 diabetes.

By Application

  • Blood glucose monitoring remained the largest segment in 2024, driven by the rising global diabetes burden.
  • Hemoglobin testing, cholesterol profiling, and DBS testing also contribute significantly to demand.

Regional Outlook

North America (USD 0.41 Billion in 2024)

Dominates due to high diabetes prevalence, Medicare coverage, and strong manufacturer presence.

Europe

Strong adoption driven by advanced healthcare systems. NHS England and Wales spent USD 13.42 million on safety lancets in 2020.

Asia Pacific

Fastest-growing region, propelled by large diabetic populations in China and India, and expanding domestic manufacturing.

Latin America

Growth supported by rising diabetes cases and expanding home monitoring adoption.

Middle East & Africa

Gradual expansion driven by government focus on non-communicable diseases.

Competitive Landscape

Key market players include BD, HTL-STREFA, Abbott, SARSTEDT AG & Co. KG, Terumo Medical Corporation, Cardinal Health, B. Braun, Ypsomed, and others. Companies are focusing on product innovation, portfolio expansion, and strategic partnerships to strengthen global market presence.

Segmentation By Type

  • Button-activated
  • Pressure/Contact-activated

By Incision Type

  • Needle
  • Blade

By Age Group

  • Adult
  • Pediatric

By Application

  • Blood Glucose Monitoring
  • Hemoglobin Testing
  • Cholesterol Testing
  • Others

By End-user

  • Hospitals & Clinics
  • Home Care
  • Others

By Region

  • North America (By Type, Incision Type, Age Group, Application, End-user, and Country)
    • U.S.
    • Canada
  • Europe (By Type, By Incision Type, Age Group, Application, End-user, and Country/Sub-Region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Type, By Incision Type, Age Group, Application, End-user, and Country/Sub-Region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Type, By Incision Type, Age Group, Application, End-user, and Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, By Incision Type, Age Group, Application, End-user, and Country/Sub-Region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Diseases, By Key Countries/Region, 2024
  • 4.2. Number of SMBG User, By Key Countries/Region, 2024
  • 4.3. Advancements in Safety Lancets
  • 4.4. Overview: Reimbursement Scenario
  • 4.5. Key Industry Developments - (Mergers, Acquisition & Partnerships, etc.)

5. Global Safety Lancets Market Analysis, Insights and Forecast, 2019-2032

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Button-activated
    • 5.1.2. Pressure/Contact-activated
  • 5.2. Market Analysis, Insights and Forecast - By Incision Type
    • 5.2.1. Needle
    • 5.2.2. Blade
  • 5.3. Market Analysis, Insights and Forecast - By Age Group
    • 5.3.1. Adult
    • 5.3.2. Pediatric
  • 5.4. Market Analysis, Insights and Forecast - By Application
    • 5.4.1. Blood Glucose Monitoring
    • 5.4.2. Hemoglobin Testing
    • 5.4.3. Cholesterol Testing
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - By End-user
    • 5.5.1. Hospitals & Clinics
    • 5.5.2. Home Care
    • 5.5.3. Others
  • 5.6. Market Analysis, Insights and Forecast - By Region
    • 5.6.1. North America
    • 5.6.2. Europe
    • 5.6.3. Asia Pacific
    • 5.6.4. Latin America
    • 5.6.5. Middle East & Africa

6. North America Safety Lancets Market Analysis, Insights and Forecast, 2019-2032

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Button-activated
    • 6.1.2. Pressure/Contact-activated
  • 6.2. Market Analysis, Insights and Forecast - By Incision Type
    • 6.2.1. Needle
    • 6.2.2. Blade
  • 6.3. Market Analysis, Insights and Forecast - By Age Group
    • 6.3.1. Adult
    • 6.3.2. Pediatric
  • 6.4. Market Analysis, Insights and Forecast - By Application
    • 6.4.1. Blood Glucose Monitoring
    • 6.4.2. Hemoglobin Testing
    • 6.4.3. Cholesterol Testing
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By End-user
    • 6.5.1. Hospitals & Clinics
    • 6.5.2. Home Care
    • 6.5.3. Others
  • 6.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 6.6.1. U.S.
    • 6.6.2. Canada

7. Europe Safety Lancets Market Analysis, Insights and Forecast, 2019-2032

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Button-activated
    • 7.1.2. Pressure/Contact-activated
  • 7.2. Market Analysis, Insights and Forecast - By Incision Type
    • 7.2.1. Needle
    • 7.2.2. Blade
  • 7.3. Market Analysis, Insights and Forecast - By Age Group
    • 7.3.1. Adult
    • 7.3.2. Pediatric
  • 7.4. Market Analysis, Insights and Forecast - By Application
    • 7.4.1. Blood Glucose Monitoring
    • 7.4.2. Hemoglobin Testing
    • 7.4.3. Cholesterol Testing
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By End-user
    • 7.5.1. Hospitals & Clinics
    • 7.5.2. Home Care
    • 7.5.3. Others
  • 7.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.6.1. Germany
    • 7.6.2. U.K.
    • 7.6.3. France
    • 7.6.4. Italy
    • 7.6.5. Spain
    • 7.6.6. Scandinavia
    • 7.6.7. Rest of Europe

8. Asia pacific Safety Lancets Market Analysis, Insights and Forecast, 2019-2032

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Button-activated
    • 8.1.2. Pressure/Contact-activated
  • 8.2. Market Analysis, Insights and Forecast - By Incision Type
    • 8.2.1. Needle
    • 8.2.2. Blade
  • 8.3. Market Analysis, Insights and Forecast - By Age Group
    • 8.3.1. Adult
    • 8.3.2. Pediatric
  • 8.4. Market Analysis, Insights and Forecast - By Application
    • 8.4.1. Blood Glucose Monitoring
    • 8.4.2. Hemoglobin Testing
    • 8.4.3. Cholesterol Testing
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By End-user
    • 8.5.1. Hospitals & Clinics
    • 8.5.2. Home Care
    • 8.5.3. Others
  • 8.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. India
    • 8.6.4. Australia
    • 8.6.5. Southeast Asia
    • 8.6.6. Rest of Asia Pacific

9. Latin America Safety Lancets Market Analysis, Insights and Forecast, 2019-2032

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Button-activated
    • 9.1.2. Pressure/Contact-activated
  • 9.2. Market Analysis, Insights and Forecast - By Incision Type
    • 9.2.1. Needle
    • 9.2.2. Blade
  • 9.3. Market Analysis, Insights and Forecast - By Age Group
    • 9.3.1. Adult
    • 9.3.2. Pediatric
  • 9.4. Market Analysis, Insights and Forecast - By Application
    • 9.4.1. Blood Glucose Monitoring
    • 9.4.2. Hemoglobin Testing
    • 9.4.3. Cholesterol Testing
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By End-user
    • 9.5.1. Hospitals & Clinics
    • 9.5.2. Home Care
    • 9.5.3. Others
  • 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.6.1. Brazil
    • 9.6.2. Mexico
    • 9.6.3. Rest of Latin America

10. Middle East & Africa Safety Lancets Market Analysis, Insights and Forecast, 2019-2032

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Button-activated
    • 10.1.2. Pressure/Contact-activated
  • 10.2. Market Analysis, Insights and Forecast - By Incision Type
    • 10.2.1. Needle
    • 10.2.2. Blade
  • 10.3. Market Analysis, Insights and Forecast - By Age Group
    • 10.3.1. Adult
    • 10.3.2. Pediatric
  • 10.4. Market Analysis, Insights and Forecast - By Application
    • 10.4.1. Blood Glucose Monitoring
    • 10.4.2. Hemoglobin Testing
    • 10.4.3. Cholesterol Testing
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By End-user
    • 10.5.1. Hospitals & Clinics
    • 10.5.2. Home Care
    • 10.5.3. Others
  • 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.6.1. GCC
    • 10.6.2. South Africa
    • 10.6.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2024)
  • 11.2. Company Profiles
    • 11.2.1. BD
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. SARSTEDT AG & Co. KG
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Greiner Bio-One International GmbH
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. HTL-STREFA (MTD Medical Technology and Devices)
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Terumo Medical Corporation
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. B. Braun SE
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Abbott
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Cardinal Health
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. YPSOMED
      • 11.2.9.1. Overview
      • 11.2.9.2. Products
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. Biosense Technologies Private Limited
      • 11.2.10.1. Overview
      • 11.2.10.2. Products
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)

List of Tables

  • Table 1:Global Safety Lancets Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 2:Global Safety Lancets Market Revenue (USD billion) Forecast, by Incision Type, 2019-2032
  • Table 3:Global Safety Lancets Market Revenue (USD billion) Forecast, by Age Group, 2019-2032
  • Table 4:Global Safety Lancets Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 5:Global Safety Lancets Market Revenue (USD billion) Forecast, by End-user 2019-2032
  • Table 6:Global Safety Lancets Market Revenue (USD billion) Forecast, by Region, 2019-2032
  • Table 7:North America Safety Lancets Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 8:North America Safety Lancets Market Revenue (USD billion) Forecast, by Incision Type, 2019-2032
  • Table 9:North America Safety Lancets Market Revenue (USD billion) Forecast, by Age Group, 2019-2032
  • Table 10:North America Safety Lancets Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 11:North America Safety Lancets Market Revenue (USD billion) Forecast, by End-user 2019-2032
  • Table 12:North America Safety Lancets Market Revenue (USD billion) Forecast, By Country, 2019-2032
  • Table 13:Europe Safety Lancets Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 14:Europe Safety Lancets Market Revenue (USD billion) Forecast, by Incision Type, 2019-2032
  • Table 15:Europe Safety Lancets Market Revenue (USD billion) Forecast, by Age Group, 2019-2032
  • Table 16:Europe Safety Lancets Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 17:Europe Safety Lancets Market Revenue (USD billion) Forecast, by End-user 2019-2032
  • Table 18:Europe Safety Lancets Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 19:Asia Pacific Safety Lancets Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 20:Asia Pacific Safety Lancets Market Revenue (USD billion) Forecast, by Incision Type, 2019-2032
  • Table 21:Asia Pacific Safety Lancets Market Revenue (USD billion) Forecast, by Age Group, 2019-2032
  • Table 22:Asia Pacific Safety Lancets Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 23:Asia Pacific Safety Lancets Market Revenue (USD billion) Forecast, by End-user 2019-2032
  • Table 24:Asia Pacific Safety Lancets Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 25:Latin America Safety Lancets Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 26:Latin America Safety Lancets Market Revenue (USD billion) Forecast, by Incision Type, 2019-2032
  • Table 27:Latin America Safety Lancets Market Revenue (USD billion) Forecast, by Age Group, 2019-2032
  • Table 28:Latin America Safety Lancets Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 29:Latin America Safety Lancets Market Revenue (USD billion) Forecast, by End-user 2019-2032
  • Table 30:Latin America Safety Lancets Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 31:Middle East & Africa Safety Lancets Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 32:Middle East & Africa Safety Lancets Market Revenue (USD billion) Forecast, by Incision Type, 2019-2032
  • Table 33:Middle East & Africa Safety Lancets Market Revenue (USD billion) Forecast, by Age Group, 2019-2032
  • Table 34:Middle East & Africa Safety Lancets Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 35:Middle East & Africa Safety Lancets Market Revenue (USD billion) Forecast, by End-user 2019-2032
  • Table 36:Middle East & Africa Safety Lancets Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

List of Figures

  • Figure 1:Global Safety Lancets Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032
  • Figure 2:Global Safety Lancets Market Value Share (%), by Type, 2024 & 2032
  • Figure 3:Global Safety Lancets Market Value Share (%), by Incision Type, 2024 & 2032
  • Figure 4:Global Safety Lancets Market Value Share (%), by Age Group, 2024 & 2032
  • Figure 5:Global Safety Lancets Market Value Share (%), by Application, 2024 & 2032
  • Figure 6:Global Safety Lancets Market Value Share (%), by End-user, 2024 & 2032
  • Figure 7:Global Safety Lancets Market Value (USD billion), by Region, 2024 & 2032
  • Figure 8:North America Safety Lancets Market Value (USD billion), by Type, 2024 & 2032
  • Figure 9:North America Safety Lancets Market Value Share (%), by Type, 2024
  • Figure 10:North America Safety Lancets Market Value Share (%), by Incision Type, 2024
  • Figure 11:North America Safety Lancets Market Value Share (%), by Incision Type, 2024
  • Figure 12:North America Safety Lancets Market Value Share (%), by Age Group, 2024
  • Figure 13:North America Safety Lancets Market Value Share (%), by Age Group, 2024
  • Figure 14:North America Safety Lancets Market Value (USD billion), by Application, 2024 & 2032
  • Figure 15:North America Safety Lancets Market Value Share (%), by Application, 2024
  • Figure 16:North America Safety Lancets Market Value (USD billion), by End-user, 2024 & 2032
  • Figure 17:North America Safety Lancets Market Value Share (%), by End-user, 2024
  • Figure 18:North America Safety Lancets Market Value (USD billion), By Country, 2024 & 2032
  • Figure 19:North America Safety Lancets Market Value Share (%), By Country, 2024
  • Figure 20:Europe Safety Lancets Market Value (USD billion), by Type, 2024 & 2032
  • Figure 21:Europe Safety Lancets Market Value Share (%), by Type, 2024
  • Figure 22:Europe Safety Lancets Market Value Share (%), by Incision Type, 2024
  • Figure 23:Europe Safety Lancets Market Value Share (%), by Incision Type, 2024
  • Figure 24:Europe Safety Lancets Market Value Share (%), by Age Group, 2024
  • Figure 25:Europe Safety Lancets Market Value Share (%), by Age Group, 2024
  • Figure 26:Europe Safety Lancets Market Value (USD billion), by Application, 2024 & 2032
  • Figure 27:Europe Safety Lancets Market Value Share (%), by Application, 2024
  • Figure 28:Europe Safety Lancets Market Value (USD billion), by End-user, 2024 & 2032
  • Figure 29:Europe Safety Lancets Market Value Share (%), by End-user, 2024
  • Figure 30:Europe Safety Lancets Market Value (USD billion), By Country/Sub-region, 2024 & 2032
  • Figure 31:Europe Safety Lancets Market Value Share (%), By Country/Sub-region, 2024
  • Figure 32:Asia Pacific Safety Lancets Market Value (USD billion), by Type, 2024 & 2032
  • Figure 33:Asia Pacific Safety Lancets Market Value Share (%), by Type, 2024
  • Figure 34:Asia Pacific Safety Lancets Market Value Share (%), by Incision Type, 2024
  • Figure 35:Asia Pacific Safety Lancets Market Value Share (%), by Incision Type, 2024
  • Figure 36:Asia Pacific Safety Lancets Market Value Share (%), by Age Group, 2024
  • Figure 37:Asia Pacific Safety Lancets Market Value Share (%), by Age Group, 2024
  • Figure 38:Asia Pacific Safety Lancets Market Value (USD billion), by Application, 2024 & 2032
  • Figure 39:Asia Pacific Safety Lancets Market Value Share (%), by Application, 2024
  • Figure 40:Asia Pacific Safety Lancets Market Value (USD billion), by End-user, 2024 & 2032
  • Figure 41:Asia Pacific Safety Lancets Market Value Share (%), by End-user, 2024
  • Figure 42:Asia Pacific Safety Lancets Market Value (USD billion), By Country/Sub-region, 2024 & 2032
  • Figure 43:Asia Pacific Safety Lancets Market Value Share (%), By Country/Sub-region, 2024
  • Figure 44:Latin America Safety Lancets Market Value (USD billion), by Type, 2024 & 2032
  • Figure 45:Latin America Safety Lancets Market Value Share (%), by Type, 2024
  • Figure 46:Latin America Safety Lancets Market Value Share (%), by Incision Type, 2024
  • Figure 47:Latin America Safety Lancets Market Value Share (%), by Incision Type, 2024
  • Figure 48:Latin America Safety Lancets Market Value Share (%), by Age Group, 2024
  • Figure 49:Latin America Safety Lancets Market Value Share (%), by Age Group, 2024
  • Figure 50:Latin America Safety Lancets Market Value (USD billion), by Application, 2024 & 2032
  • Figure 51:Latin America Safety Lancets Market Value Share (%), by Application, 2024
  • Figure 52:Latin America Safety Lancets Market Value (USD billion), by End-user, 2024 & 2032
  • Figure 53:Latin America Safety Lancets Market Value Share (%), by End-user, 2024
  • Figure 54:Latin America Safety Lancets Market Value (USD billion), By Country/Sub-region, 2024 & 2032
  • Figure 55:Latin America Safety Lancets Market Value Share (%), By Country/Sub-region, 2024
  • Figure 56:Middle East & Africa Safety Lancets Market Value (USD billion), by Type, 2024 & 2032
  • Figure 57:Middle East & Africa Safety Lancets Market Value Share (%), by Type, 2024
  • Figure 58:Middle East & Africa Safety Lancets Market Value Share (%), by Incision Type, 2024
  • Figure 59:Middle East & Africa Safety Lancets Market Value Share (%), by Incision Type, 2024
  • Figure 60:Middle East & Africa Safety Lancets Market Value Share (%), by Age Group, 2024
  • Figure 61:Middle East & Africa Safety Lancets Market Value Share (%), by Age Group, 2024
  • Figure 62:Middle East & Africa Safety Lancets Market Value (USD billion), by Application, 2024 & 2032
  • Figure 63:Middle East & Africa Safety Lancets Market Value Share (%), by Application, 2024
  • Figure 64:Middle East & Africa Safety Lancets Market Value (USD billion), by End-user, 2024 & 2032
  • Figure 65:Middle East & Africa Safety Lancets Market Value Share (%), by End-user, 2024
  • Figure 66:Middle East & Africa Safety Lancets Market Value (USD billion), By Country/Sub-region, 2024 & 2032
  • Figure 67:Middle East & Africa Safety Lancets Market Value Share (%), By Country/Sub-region, 2024
  • Figure 68:Global Safety Lancets Market Share (%), By Company, 2024